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Social Determinants and the Health of
Drug Users: Socioeconomic Status,
Homelessness, and Incarceration
S Y N O P S I S
Objectives: This article reviews the evidence on the adverse health
consequences of low socioeconomic status, homelessness, and
incarceration among drug users.
Observations: Social and economic factors shape risk behavior and
the health of drug users. They affect health indirectly by shaping
individual drug-use behavior; they affect health directly by affecting
the availability of resources, access to social welfare systems,
marginalization, and compliance with medication. Minority groups
experience a disproportionately high level of the social factors that
adversely affect health, factors that contribute to disparities in health
among drug users.
Conclusion: Public health interventions aimed at improving the
health of drug users must address the social factors that accompany
and exacerbate the health consequences of illicit drug use.
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INTRODUCTION
Renewed interest in the persistent, and growing, health
inequalities in the United States has resulted in new
research and federal initiatives aimed at understanding
and reducing disparities in health across racial and
ethnic groups. Consistent with the Public Health
Service’s focus on health disparities, a National Institute
on Drug Abuse initiative is considering the role of
differential drug use and its consequences within and
across racial and ethnic groups in the United States.
This article argues that social factors are
determinants of the health of drug users and contribute
to both differential drug use behavior and differential
morbidity among drug users from different racial and
ethnic groups. Implicit in this argument is that social
factors associated with drug use are not consequences
but rather circumstances that are inextricably
intertwined with drug use patterns and shape the
health of drug users. To illustrate this thesis, we focus
on three social factors associated with health
differentials among drug users: socioeconomic status
(SES), homelessness, and incarceration. SES is often
conceptualized as a root cause of health inequalities.
Homelessness and incarceration are social
circumstances that frequently co-occur with poor SES.
They also independently contribute to adverse health
outcomes among drug users.
We focus on the role of these three factors in
shaping health disparities among drug users. Although
we do not discuss how social factors also set the stage
for disparities in health between drug users and
nonusers, our observations about the role of social
factors can guide thinking about why drug users have
worse health outcomes in general. We focus our
discussion on people who inject drugs, but, in light of the
relative paucity of data specific to injection-drug users, we
also refer to research about illicit drug users in general.
Although the prevalence of drug use in the general
population is small, disparities in health among drug
users contribute to larger population-level health
disparities. Examination of the role social factors play
in determining health disparities among users
illustrates the role these same factors play in
determining health disparities in the United States.
SOCIAL DETERMINANTS OF THE HEALTH OF
DRUG USERS AND OF HEALTH DISPARITIES
ACROSS ETHNIC GROUPS
The universe of social factors has been referred to as
the “social environment.” The social environment
includes the contextual forces, norms, and social
relationships within which individuals interact and
function.1 Features of the social environment such as
social hierarchy (income distribution, workplace
control), public policies (housing, education), cultural
norms, and social relationships (social networks,
discrimination) affect health and well-being. These
social factors are increasingly referred to as “social
determinants,” to reflect their role in shaping both
macro-level and individual-level risk factors and health
outcomes.2
Several conceptual models describe the causal
relationship between social and economic factors on
the one hand and disease and individual well-being on
the other.3-6 Different models posit different pathways
through which social determinants affect health, but
all agree that specific social factors play a role in
determining health, indirectly or directly, either
detrimentally or protectively.7,8 Some models suggest
that SES (generally defined as the highest educational
level, income, or employment) is a fundamental factor,
determining power, prestige, and access to resources
and underlying the relation between other social factors
and health.5
The health of drug users is inextricably bound to
their social environment. Drug-taking and drug-use risk
behaviors are affected by social processes, and the
health of drug users is a product of both drug-use
behaviors and social determinants. Social determinants
can directly shape health risk behaviors.9 Homeless
drug users, for example, are more likely to engage in
high-risk sexual activity.10 Social determinants can
establish the living conditions and resources that
indirectly exacerbate the consequences of drug use.
For example, inadequate housing increases the
likelihood of infectious disease transmission, social
relationships offer protective financial and emotional
resources, and more cohesive neighborhoods have a
greater likelihood of providing appropriate care.
The role of social determinants is particularly
relevant to the health of minority drug users. Minorities
report levels of drug use similar to or lower than
nonminorities.11 But minorities, particularly
socioeconomically disadvantaged minority drug users,
experience a disproportionate number of health
consequences from drug use.12,13 This health disparity
is apparent in the incidence of HIV and AIDS. Injection
drug use is the second most common risk factor for
HIV infection among men and women in the United
States. The incidence of HIV and AIDS is growing,
primarily among African Americans and Hispanics.14
The incidence of AIDS among African Americans was
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66 per 100,000 in 1999, more than twice the rate for
Hispanic Americans and eight times the rate for
whites.15 Some 79% of new drug-related AIDS cases
were among minority ethnic groups, and 67% of
cumulative drug-related AIDS cases for women through
1999 were among African American and Hispanic
American women.15 Other adverse health outcomes
associated with drug use also occur disproportionately
among minorities. Drug overdose fatality rates are
higher for minorities than for whites,16,17 and the high
rates of homicide for young African Americans and
Hispanic Americans are likely due to involvement with
drug use and the drug trade.18,19
Specific drug use patterns are associated with
different levels of adverse health outcomes. Sharing
needles, using speedballs, sharing cookers, and
injecting in a shooting gallery are associated with higher
risk of infectious disease transmission;20,21 polydrug
abuse and use of drugs in unfamiliar surroundings are
associated with high drug-related mortality;22 and risky
sex behaviors by frequent drug users increase the
infectious disease burden among injection-drug users
(IDUs).23,24
Although these individual risk factors can explain
some of the unequal burden of morbidity and mortality
among racial and ethnic groups, risk behavior alone
does not sufficiently explain these disparities. Although
different injection practices may explain some of the
higher seroprevalence of HIV among African
Americans,25 risk behaviors do not fully explain the
disproportionate burden of HIV incidence African
Americans bear. Research suggests that African
American drug users have disproportionately high rates
of HIV even after adjusting for drug use and other risk
behaviors,20,26,27 suggesting that factors other than
individual-level drug-use behavior may be responsible
for the differential rates of HIV across racial and ethnic
groups of drug users.
Drug-use risk behavior itself is shaped by larger
contextual factors. Studies of risk factors for HIV
infection in IDUs have long suggested that differences
in both behavior and the social setting of drug use are
related to risks for HIV infection.28 Models that predict
drug-use behavior have also demonstrated that various
other factors, including the location of drug use, are
significant predictors of drug injection frequency.29
Therefore, accounting only for individual-level risk
behavior fails to fully explain the variability in HIV
incidence among individuals.
Poverty, scant and poorer quality resources,
segregation, and discrimination (including racial
profiling) are among the adverse social factors that
disproportionately affect many minority communities
in the United States.30-32 Since these factors are known
to be associated with poorer health in the general
population, it is plausible that the uneven concen-
tration of these factors in certain ethnic groups of drug
users also contributes to the disparities in health
outcomes among those groups.
To illustrate the relationship between social
determinants and adverse health outcomes for
drug users, we examine SES, homelessness,
and incarceration. Although homelessness and
incarceration are frequently referred to as
consequences of drug use, we consider them as social
circumstances that are responsible for shaping health
differentials among drug users. A simple model
summarizing our conceptualization of the role of these
social determinants in the health of drug users is
provided in figure 1.
We discuss potential mechanisms through which
these social factors likely affect the health of IDUs,
specifically, drug-use risk behavior, access to social
services and health resources, compliance with
appropriate therapy, and social marginalization.
Understanding the social determinants of these
outcomes could help guide public health interventions.
Socioeconomic Status. SES is a fundamental cause of
disease.5 It also affects other social factors, such as access
to resources or discrimination.33 Numerous studies have
shown the existence of a social gradient, in which rates
of morbidity and mortality decrease directly and
proportionately with each increase in level of income
or education.2,34 Evidence shows an association between
occupational status and heart disease mortality,35
Figure 1. Conceptual model of the relationships
between socioeconomic status, homelessness, and
incarceration and the health of illicit drug users
Note: The model has been simplified to illustrate only the
social factors discussed in this article.
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educational status and disease prevalence,34 and income
and all causes of mortality.36
The association between poor socioeconomic
conditions, multiple health risks, and greater
morbidity and mortality among drug users is
suggested by several ecologic studies. 37-39 An
association between neighborhood-level SES and
AIDS survival among drug users has also been shown.40
SES may play a role in determining high-risk
behaviors that are immediately linked to poor health
as well as in shaping access to health care, the quality
of health care received, behavioral norms, and
preventive behavior of drug users.
Data describing the role of SES among drug users
are sparse, and they inadequately measure the social
standing of drug users. Nevertheless, the data do show
that differences in SES are associated with differential
health outcomes among drug users, not merely as a
potential confounder for individual risk factors but also
as a social determinant that contributes to the health
status of this group. Although illicit drugs are used by
people in all strata of SES,41 drug-related morbidity and
mortality are disproportionately higher among lower
SES groups.33,42,43
The relationships among SES, ethnicity, drug use,
and health are complex. A multistate surveillance
project found that among IDUs, 35% of white men,
64% of black men, and 67% of Puerto Rican men had
not completed 12 years of school overall.44 Other
research has corroborated a high prevalence of school
dropout status among Puerto Rican IDUs.45 School
dropout status and early misbehavior in turn have been
associated with higher likelihood of injection-drug
use,46-48 and limited economic opportunity has been
associated with risky sexual practices among drug
users.49
Inferences about a role for SES in HIV prevalences
can be made from two studies. Data from a five-city study
conducted in 1987-91 found variations in injection risk
behaviors and overall HIV risk among drug users.
African Americans were at higher than average risk for
HIV in four cities, while Puerto Ricans faced higher
risk in two cities.50 The same study documented
increased risk for HIV among these minorities
independent of risk behavior. Factors other than the
risky injection practices thus appear to contribute to
the risk for HIV.
A study of risk behavior in four Ohio cities
comparing African American and white IDUs showed
significant differences between the two groups for drug
use prevalence, risky injection behavior, and treatment
frequency. 51 These differences in risk behaviors in four
cities in relatively close geographic proximity may
indicate a role for SES factors in the health of IDUs.
Factors that may affect access to health care,
including minority status, low educational attainment,
and injection drug use, have been shown to contribute
to differences in health status among people with HIV.52
IDUs have a greater need for treatment and are less
likely to receive needed treatment than are non-
users.53,54 IDUs who are HIV-positive have higher rates
of emergency room visits (compared with outpatient
clinic and physician visits) than non-IDU HIV-positive
patients; that is, they rely more on ad hoc disease
management.55
Factors such as poor access to risk-reduction
information and differences in quality of information
received may play a role in stratifying health risk within
groups of IDUs.52 The poor level of education among
IDUs56 may, in part, be responsible for poor knowledge
about disease and the risks for diseases among IDUs as
a group.57,58 Poorer quality communication between
clinicians and low-income patients regarding end-stage
AIDS and care has been observed59 and may apply to
IDUs.
IDUs do not receive appropriate preventive care,60
have limited access to medical care,61 and frequently
receive substandard medical care.62,63 A Baltimore study
based on self-report conducted in 1996-97 found that
49% of IDUs had received no antiretroviral therapy and
that only 14% had received the recommended triple-
combination therapy with a protease inhibitor.64 These
differences in care reflect socioeconomic disparities.
Low SES drug users are also less likely than drug users
with higher SES to engage in appropriate preventive
behavior, and they are more likely to focus on immediate
risks in their lives, including poverty and joblessness.65
Together this body of research suggests that factors
beyond the immediate individual risk behaviors play a
role in the health disparities documented among IDUs
of different socioeconomic levels.51
Homelessness. Homelessness has been a significant
public health concern in North America for the past
20 years. Broad social processes, such as changes in
economic opportunities, and institutional factors, such
as fragmentation of social services, have been associated
with a rise in prevalence and incidence of homelessness
during the past two decades in the United States.66-69 In
a national representative survey, 7% of respondents said
that they had been homeless at some point in their
lives.70 It has been estimated that half a million
Americans are living in shelters or are without shelter
at any given time.71 In the general population,
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homelessness has been associated with high levels of all-
cause mortality, mental health disorders, and prevalence
of infectious disease such as tuberculosis.72-74
IDUs make up a significant proportion of the
homeless in the United States; 10%-20% of homeless
people are estimated to abuse drugs,75,76 with estimates
of lifetime prevalence of 25%-50%.77 It is difficult to
determine the extent to which drug use causes
homelessness. One-quarter of homeless people in a
New Haven, Connecticut, survey identified drug use as
the primary reason for their homelessness.78
Illicit drug use is a significant risk for poor health
and high-risk behavior among homeless adults.79-83
Injection drug use increases the likelihood of death
among homeless adults.72 The experience of
homelessness itself is associated with higher rates of
HIV infection, exposure to hepatitis B,84,85 and poor
mental health86 among IDUs. In one prospective study,
42% of IDUs who remained HIV-negative over the
course of the 10-year study reported a history of
homelessness; 59% of participants who seroconverted
during the study reported homelessness.87
Homelessness likely influences the well-being of
IDUs because of their high-risk behavior, inadequate
access to medical care, and failure to comply with
treatment regimens. Homeless people are poor; tend
to practice few, if any, risk-reduction behaviors; and tend
to engage in high-risk behaviors, such as trading sex
for drugs and money and88,89 engaging in high-risk sex.90
Homeless IDUs are more likely than IDUs who are not
homeless to be young and to be arrested.10 Lack of
appropriate living arrangements has also been
associated with high prevalence of risk behaviors by
women.91 Mental illness, high among the homeless,90
compounds high-risk drug-use behavior by homeless
IDUs73,86 and by drug users with few socioeconomic
resources.92 High frequency of drug injection and use
of crack are predictors of HIV infection in homeless
IDUs. These HIV risk behaviors are associated with the
severity of homeless circumstances, perhaps indicating
a dose-response relationship.93
In conjunction with greater high-risk sexual and
drug-use behavior, homeless IDUs also face risks to
well-being that relate directly to the state of
homelessness itself. Cohabitation in overcrowded
homeless shelters increases the risk of airborne
infections, such as tuberculosis.94 The loss of social
support is associated with low compliance with
medication.95,96 Noncompliance with tuberculosis
therapy is, in turn, associated with a 10-fold increase
in poor outcomes from treatment and contributes to
treatment failures.97 Injection drug use behavior has
been particularly implicated in tuberculosis infection
in women.74
Homelessness also limits users’ access to
appropriate drug treatment. In general, regular
attendance at a drug treatment program is associated
with significant reductions in drug use.98,99 Homeless
IDUs are not likely to have medical insurance, which
limits their access to medical care.100 For example,
methadone maintenance treatment programs are a
primary method for reducing drug-use risk behavior
and morbidity among IDUs.101 Consistent use of
methadone maintenance treatment has been associated
with more appropriate use of antiretroviral therapy and
significantly lower inpatient expenditures related to
drug use.102,103 Enrollment in methadone programs is
inversely associated with homelessness and recent
incarceration.104
Incarceration. The number of inmates in the U.S.
correctional system has increased from less than
500,000 in 1980 to roughly 1.9 million in 1999, with a
5.7% average annual increase between 1990 and
1999.105 Inmates are overwhelmingly ethnic minorities
(54% are African American or Hispanic).106 The high
increase in the jail and prison population is partly due
to a nationwide public policy of mandatory sentencing
for drug offenders.107 The incarceration rate for drug
offenders increased from 15 to 148 per 100,000 adults
from 1980 to 1996.108
The percentages of drug offenders in both state
and federal correctional facilities have increased
substantially. In 1980 drug offenders accounted for 6%
of inmates in state and 25% of inmates in federal
correctional facilities. These figures rose to 20% and
46% in 1999-2000.109 Precise estimates of the
proportion of IDUs among prison inmates are difficult
to obtain. Analyses of several surveys estimate that one-
third to two-thirds of inmates had previously used
injection drugs110-114 and that most continue to do so
while incarcerated.115,116 The growing number of drug
users in the U.S. prison system suggests that
incarceration is an increasingly important social factor
resulting from drug-use behavior, which in turn affects
the well-being of IDUs.
Incarceration is a particularly difficult social
circumstance for drug users. Incarceration is associated
with other social factors related to poor health
(particularly SES) and also presents direct threats to
the health of drug users. Prisons can benefit inmates
by offering access to diagnosis and treatment, but they
concentrate people, which heightens risk behavior and
thus the transmission of infectious diseases. In addition,
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the common cycle of incarceration—release and
reentry—particularly among people of lower SES,
increases morbidity and mortality for incarcerated drug
users.
The prevalences of infectious diseases, such as HIV
infection, sexually transmitted diseases, hepatitis B and
C, and tuberculosis, are higher in the correctional
population than in the U.S. population at large.117-121
Reported HIV rates in prisons are higher among
women, ethnic minorities, and IDUs.122-23 Among IDUs
a history of arrest often coincides with low SES110,114 and
a history of homelessness,124 further compounding their
risks for disease. A survey of 1,405 subjects in Baltimore
found that a previous arrest was twice as likely for IDUs
with less than an 11th grade education than for IDUs
with at least an 11th grade education and 1.5 times
more likely for IDUs with more than 1 year of
unemployment in the past 10 years than those with less
than 1 year of unemployment.125
Prisons are high-risk environments in which high-
risk behaviors are prevalent. Incarceration directly and
indirectly affects risk behavior of inmates and
contributes to poorer health for IDUs who have been in
prison. Incarceration likely affects the well-being of
IDUs because of their changes in risky behaviors and
through the cycle of incarceration, which limits IDUs’
access to health resources.
Injection drug-use rates for prisoners are about
20 times higher than for the general population.110,115
One study showed that for every year of imprisonment
the risk of injection-drug use in prison increased by
about 17%.116 In another study, 73% of inmates who
were injecting drugs reported having shared needles
while in prison.115 Another analysis showed that women
inmates who were IDUs reported needle-sharing (62%)
more often than male IDU inmates (43%).126 Risky
sex is also higher among incarcerated IDUs,127,128 with
a high prevalence of anal sex and unprotected
intercourse.126,129
Surveys of prisoners show that a significant risk
factor for HIV infection is prior incarceration,
suggesting that people who cycle through the prison
system add to the burden of disease both inside and
outside the prison environment.130 A study of IDUs in
Greek prisons showed that inmates with previous drug-
related convictions were twice as likely as those without
previous drug-related convictions to inject drugs in
prison.116
Limited availability of primary prevention resources
(such as condoms and bleach), poor medical screening
at admission, and limited ongoing mental health
services are barriers to public health interventions.131,132
The consequence of the high turnover rate is that many
inmates are likely to return to their previous high-risk
environments, which are conducive to continued
spread of disease and introduction of new high-risk
behaviors.133 Limited availability of housing, benefit
programs, and preventive and treatment services in
these former inmates’ communities compounds their
health problems.134 Incarceration is thus a risk for
disease amplification both within prisons and in the
communities that inmates come from and go to.
Few conclusive studies have been conducted on
the risks faced by IDUs immediately after release from
prison. One study showed a high likelihood of drug-
related death immediately after prison release. Another
found that mortality of former prisoners during the first
year after release was four times the age-adjusted rate
in the general population.135 Another study found that
mortality from overdose was 7 times higher in the first
2 weeks after release than in the next 10 weeks.136 The
likely factors associated with this high mortality include
loss of tolerance to opiates while in prison, psychological
stress associated with re-entry into the community, and
the increased opportunity for drug use and other high-
risk behavior.
DISCUSSION
Illicit drug use is a high-risk behavior associated with
immediate and long-term health consequences. While
individual risk factors are certainly associated with
health outcomes, social factors are determinants of both
risky drug-use behavior and the health consequences
of drug use. These social determinants, including SES,
homelessness, and incarceration, frequently coincide
and interact to the detriment of IDUs’ health. Other
social determinants,7 such as discrimination,137
instrumental social support,138 and residential
segregation,139 also affect the health of drug users,
through various mechanisms, including disinvestment
in human and social resources. These social factors also
play a significant role in creating health differentials
between drug users and the general population.
Research on the role of these factors in determining
the health of drug users—particularly research
exploring the mechanisms that explain these
associations—is sparse.
Much research on the health of drug users
represents either a physiologic or medical inquiry into
the link between drug use and health outcomes140,141 or
behavioral research on drug users’ risk behavior and
health outcomes.142 Behavioral research fits a traditional
epidemiologic risk factor model. Although this work
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has guided public health interventions and some has
been successful in reducing the burden of disease
among IDUs,143 it does not recognize the fundamental
social circumstances that shape behavior and ultimately
influence the health of drug users. Underspecification
of the range of factors associated with risk behaviors
and health outcomes can bias epidemiologic inquiry144
and limit the potential scope of successful
interventions.
As long as socioeconomic disadvantage remains
concentrated among specific ethnic groups in the
United States, there exists a strong imperative for
improved research on, and intervention for, these social
determinants. Research on the mechanisms of action
of social determinants is particularly important for
public health practice. For example, while recognizing
that incarcerated IDUs have poor health outcomes is
useful, understanding that conditions at the time of
prison discharge might be a key mechanism through
which incarceration affects health suggests avenues for
intervention.
The U.S. policy of using sanctions to discourage
people from using drugs marginalizes people of lower
SES who live in poor neighborhoods, are homeless, or
have been in jail, exacerbating public health problems.
Providing education and information to people to
change individual behaviors is a necessary but
insufficient response. Public health interventions
aimed at affecting individual risk behavior or the
immediate risk to drug users’ health are bound to fall
short. A full spectrum of interventions encompassing
macro-level considerations (such as policy change to
increase economic opportunity and decrease
homelessness) and individual-level factors (such as
those targeted by many behavioral interventions) should
be considered in order to fully address the
determinants of disease among drug users.
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